IP Verse

Purdue Pharma L.P. V. Elite Laboratories, Inc. - 2:23-cv-22221

Explore the details of the Purdue Pharma L.P. V. Elite Laboratories, Inc. case under case number 2:23-cv-22221 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
2:23-cv-22221
Filing Date
Nov 9, 2023
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved in the Case

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
PURDUE PHARMA L.P. -
RHODES TECHNOLOGIES -
ELITE LABORATORIES, INC. -

Patents Involved in the Case

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Nov 9, 2023Corporate Disclosure Statement by PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P., RHODES TECHNOLOGIES. (FANG, WAYNE) (Entered: 11/09/2023)PACER Document
Nov 9, 2023COMPLAINT against ELITE LABORATORIES, INC., ELITE PHARMACEUTICALS, INC. ( Filing and Admin fee $ 402 receipt number ANJDC-14862247), filed by PURDUE PHARMA L.P., RHODES TECHNOLOGIES, PURDUE PHARMACEUTICALS L.P.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Form AO 120 (Report on the Filing or Determination of an Action Regarding a Patent or Trademark), # 17 Civil Cover Sheet)(FANG, WAYNE) (Entered: 11/09/2023)PACER Document